Antibiotic Resistance in Adult Patients with Urinary Tract Infection due to Escherichia Coli
Abstract
Objective: To determine emerging antibiotic resistance of Escherichia Coli among isolated from the patients with urinary tract infection. Study Design: Cross-sectional study. Place and Duration of Study: Pathology Department, Sahara Medical College, Narowal Pakistan, from Mar to Aug 2022. Methodology: Two hundred cases of multi drug resistance urinary tract infection (UTI) were studied, and E. coli was isolated in their urine specimen. Cases of either gender were included with age >15 years. Data of the patients was documented on a proforma regarding demographic data, WBC count, urine culture and antibiotic susceptibility pattern result of the isolated pathogen. After detection of the pathogen (E. coli), antibiotic susceptibility patter was determined using Kirby Bauer disc diffusion method on Mueller Hinton agar. Antibiotic susceptibility of E. coli was determined against commonly used antibiotics. Results: In our study, multidrug resistant Escherichia Coli (E. coli) was detected in 139(69.5%) cases. There were 78(39.0%) males and 122(61.8%) females. Age of the patients ranged from 14-65 years, with a mean age of 33.4±9.1 years. One hundred and seventy-one (85.5%) cases were resistant to cephalosporins, 173(86.5%) to quinolones, 86(43.0%) to aminoglycosides, and 27(13.5%) were resistant to carbapenems. Conclusion: Multidrug resistant E. coli infection is common among patients with urinary tract infection. E. coli was resistant to most of the commonly used antibiotics, but…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.